| Name | Cvs Pharmacy #08263 |
|---|---|
| Organization Name | Oklahoma Cvs Pharmacy Llc |
| Location | 2110 S Harvard Ave, Tulsa, Oklahoma 74114 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (918) 749-5438 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Aeterna Zentaris Inc. today announced that final Phase 2 data demonstrated that the combination of perifosine, its oral AKT inhibitor, and sorafenib, was well tolerated by heavily pretreated patients with relapsed/refractory lymphomas.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced positive results from the Phase 1 portion of its Phase 1/1b study of defactinib (VS-6063) in combination with paclitaxel in patients with ovarian cancer that were presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
President Barack Obama and Democratic leaders have repeatedly praised integrated health care for its ability to improve safety and quality while reducing costs, citing examples such as the Mayo Clinic. But health economists worry that such consolidation may actually increase costs and could lead to monopolies.
A review of previous studies indicates that use of a class of medications known as "incretin-based therapy", which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic therapies.
› Verified 2 days ago
| NPI Number | 1063706745 |
| Organization Name | OKLAHOMA CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY #08263 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2110 S Harvard Ave, Tulsa, OK 74114 |
| Phone Number | 918-749-5438 |
News Archive
Aeterna Zentaris Inc. today announced that final Phase 2 data demonstrated that the combination of perifosine, its oral AKT inhibitor, and sorafenib, was well tolerated by heavily pretreated patients with relapsed/refractory lymphomas.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced positive results from the Phase 1 portion of its Phase 1/1b study of defactinib (VS-6063) in combination with paclitaxel in patients with ovarian cancer that were presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
President Barack Obama and Democratic leaders have repeatedly praised integrated health care for its ability to improve safety and quality while reducing costs, citing examples such as the Mayo Clinic. But health economists worry that such consolidation may actually increase costs and could lead to monopolies.
A review of previous studies indicates that use of a class of medications known as "incretin-based therapy", which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic therapies.
› Verified 2 days ago
News Archive
Aeterna Zentaris Inc. today announced that final Phase 2 data demonstrated that the combination of perifosine, its oral AKT inhibitor, and sorafenib, was well tolerated by heavily pretreated patients with relapsed/refractory lymphomas.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced positive results from the Phase 1 portion of its Phase 1/1b study of defactinib (VS-6063) in combination with paclitaxel in patients with ovarian cancer that were presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
President Barack Obama and Democratic leaders have repeatedly praised integrated health care for its ability to improve safety and quality while reducing costs, citing examples such as the Mayo Clinic. But health economists worry that such consolidation may actually increase costs and could lead to monopolies.
A review of previous studies indicates that use of a class of medications known as "incretin-based therapy", which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic therapies.
› Verified 2 days ago
Preferred Pediatric Home Health Car Type: Pharmacy Location: 12331 E 60th St, Tulsa, Oklahoma 74146 Phone: (918) 252-2000 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11414 E 51st St, Tulsa, Oklahoma 74146 Phone: (918) 252-7082 | |
American Medical Rental & Sales Type: Durable Medical Equipment & Medical Supplies Supplier Location: 12206 E 51st St, Tulsa, Oklahoma 74146 Phone: (918) 622-4444 | |
Freeland Brown Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4112 South Peoria Ave, Tulsa, Oklahoma 74105 Phone: (918) 743-4491 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5545 E 41st St, Tulsa, Oklahoma 74135 Phone: (918) 622-7895 |